The generational fault line in cancer risk

For much of the twentieth century, the story of public health was one of steady, almost predictable progress. Life expectancy climbed, childhood mortality plummeted, and diseases that once terrorised communities were tamed by vaccines and antibiotics. Cancer, when it appeared, was understood largely as a disease of ageing, a cruel lottery that one might draw in later life. That comfortable narrative has begun to fray. Since the turn of the century, a quiet but persistent shift has been underway, one that researchers are only now beginning to map in detail: a rise in early-onset cancers, those diagnosed in adults under fifty, across a range of types and in multiple countries.

A major report from the World Cancer Research Fund, which examined registry data from England, the United States and the Netherlands over two decades, found increases in at least seven cancers among younger adults in England alone. For women under fifty, breast, bowel, uterine, kidney, liver, pancreatic and stomach cancers all rose. For men, bowel, kidney, liver, pancreatic and prostate cancers climbed. The trend is not confined to wealthy nations. Studies from Latin America show similar patterns, with particularly steep rises in colorectal cancer in Chile, Argentina and Ecuador. In Brazil, one major cancer centre reported a five-fold increase in colorectal cancer patients under fifty between 2000 and 2023.

The immediate question, of course, is whether we are simply finding more cases because we are looking harder. Improved diagnostic tools and greater awareness undoubtedly play a role. A study of pancreatic cancer in young adults in the United States found that the rise consisted almost entirely of early-stage tumours, suggesting that better detection, rather than a true increase in incidence, might explain the numbers. Yet the picture is not so simple. For colorectal cancer, the data look different: some studies show increases in advanced-stage disease as well, which points to a genuine rise in cases, not merely an artefact of screening. As one epidemiologist put it, three times a small number is still a small number, but the direction of travel is troubling.

The search for culprits

What, then, has changed between the childhood of a baby boomer and that of a millennial? The most obvious candidate is the transformation of our diets and bodies. Since the 1990s, global obesity rates have more than doubled among adults and quadrupled among adolescents. In England, roughly two-thirds of adults are now either overweight or living with obesity. Excess body fat, particularly around the abdomen and vital organs, is a known contributor to chronic inflammation, insulin resistance and metabolic dysfunction, all of which are implicated in cancer development. The World Health Organization’s cancer research arm has classified obesity as an established cause of at least thirteen cancers. One review found that young adults with obesity were almost twice as likely to develop colorectal cancer before the age of fifty.

And yet the obesity explanation, compelling as it is, does not account for everything. For premenopausal women, a higher body mass index is actually associated with a slightly lower risk of breast cancer, the opposite of the pattern seen in older women. This anomaly has pushed scientists to look beyond diet and exercise. Attention has turned to the broader environment: the air we breathe, the water we drink, the plastics and chemicals that have become ubiquitous over the past half-century. Identifying a single culprit has proved extraordinarily difficult. Cancer can develop decades after exposure to a toxic substance, and over a lifetime each of us encounters a complex cocktail of pollutants. Disentangling whether a harmful exposure occurred in the womb, during childhood or in adulthood is a formidable scientific challenge.

Ultra-processed foods and microplastics have attracted considerable public attention, and researchers acknowledge the plausibility of a link. But the evidence remains inconclusive. The same caution applies to the idea that Westernised diets and sedentary lifestyles are exporting a cancer risk profile to middle-income countries as their economies develop. While the pattern is suggestive, scientists stress that correlation is not causation and that more robust data are needed before firm conclusions can be drawn.

What we can and cannot control

Amid the uncertainty, one success story offers a counterpoint. Lung cancer rates among young people have fallen, a direct result of decades of anti-smoking campaigns and widespread public awareness of the link between tobacco and the disease. It is a reminder that some risk factors are modifiable and that public health interventions can work. Yet researchers caution against reducing the conversation to individual responsibility. Estimates suggest that only around forty percent of cancers at a population level are attributable to behaviours a person can change, such as smoking, drinking, diet, physical activity and weight. The remaining sixty percent is a mix of ageing, genetic susceptibility, infections, possible environmental exposures and what can only be described as chance.

This statistic is humbling. It should also temper the instinct, common among patients receiving a diagnosis, to search for personal blame. The science is simply not granular enough to tell any individual why their cells mutated when they did. What the data do tell us is that something has shifted at a population level, and that the shift demands a response that is collective rather than individual: better cancer registration systems, particularly in countries where data are patchy, and sustained investment in research that can untangle the interplay of diet, environment and genes over a lifetime. The rise in early-onset cancer is not a mystery that will yield to a single elegant solution. It is a slow-burning puzzle, and one that will require patience, rigour and a willingness to sit with uncertainty for some time yet.